logo
  • Home
  • About us
    • Our Approach
    • Our Partners
    • Our Campuses
    • Synthetic Biology
  • Portfolio
    • Medical/ Biotechnology
    • Environmental Technologies
    • ICT
    • Software
    • Services
    • Exits
    • Other
  • RSF People
  • The Fund Manager
  • FAQs
  • News & Blog
    • Events
    • Blog
  • Contact
Rainbow seed fund: an early-stage VC fund for expanding science & tech campuses in the field of synthetic biology
  • Advantage Growth Fund
  • Early Advantage
  • Exceed Partnership
  • HSBC Enterprise Fund
  • Stephenson LP

The Fund Manager

The Rainbow Seed Fund is independently managed by specialist venture capital firm Midven. Midven currently manages 5 other funds representing a total of £79m under management. Each of the funds has specific investment criteria but share the commonality of all being focused on early stage and SME businesses. Click on the individual fund logos below to find out more about each fund.

Advantage Growth Fund

The Advantage Growth Fund is a £17.5m fund established in 2003 as part of the UK government Regional Venture Capital Fund Initiative to invest in West Midlands based small and medium sized enterprises.

Early Advantage

The Early Advantage was launched In December 2009 to provide investment, alongside business angels and other private sector investors, in early stage and small businesses within the West Midlands.

Exceed Partnership

The Exceed Partnership was launched in March 2010 to provide expansion and development capital to West Midlands based businesses. The Fund is targeting businesses across a broad range of sectors with the potential to deliver high levels of growth and profitability.

HSBC Enterprise Fund

The HSBC Enterprise Fund was established in July 1997 by the merger of separate HSBC sponsored funds for the East and West Midlands to create a £6.4m fund.

Stephenson LP

Stephenson LP is a co-investment fund established in 2014  with funding having been provided by the Institution of Mechanical Engineers.


Blog

Genome editing techniques: The science and the ethics Synthetic biology brings hope for Chlamydia vaccine Taking experiments from lab to market – thoughts from SynBioBeta London Read more
  • Register

    Register to receive updates on Rainbow, Midven and our portfolio companies

    Register

  • Latest Tweets

    Join the #meetsynbio campaign and put a face to synthetic biology: goo.gl/GY7qHC

    Yesterday from RainbowSeedFund's Twitter via Hootsuite

    Kenilworth firm doubles workforce @aeristech read the press release here ow.ly/SSF95 pic.twitter.com/etdGZPdK8c

    Yesterday from RainbowSeedFund's Twitter via Hootsuite

    If any of our Portfolio comps would like to join us this morn for coffee& cake its for a good cause at our BhamOffice pic.twitter.com/gvUmlkp5hW

    Yesterday from RainbowSeedFund's Twitter via Hootsuite

    Are you a young #biotech entrpreneur? Check out the Biotechnology YES competition: goo.gl/Yx8ceV

    About a day ago from RainbowSeedFund's Twitter via Hootsuite

    Have you seen @WhiskTeam in the @FT today check it out here ow.ly/SNcof

    About 3 days ago from RainbowSeedFund's Twitter via Hootsuite

  • STAY IN TOUCH

    Office +44(0)121 710 1990
    Email:

    linkedin

    twitterFollow @RainbowSeedFund

  • Copyright Info

    © Rainbow Seed Fund 2015. All Rights Reserved. Midven Limited is authorised and regulated by the Financial conduct authority FRN 148549. Company Registration No.: 2500898 Registered Address: Cavendish House 39 - Birmingham ,
  • Website by MJ Design